For years, the beauty aisle at CVS has felt like a well-kept secret hiding in plain sight—sandwiched between prescription drop-offs and shelves of seasonal candy. That dynamic may be about to change dramatically. With CVS Health’s surprise announcement that it will separate its retail pharmacy arm from its sprawling health care and insurance businesses by 2028, industry insiders are asking a provocative question: Could this spin-off finally turn the drugstore’s front-end beauty and wellness section from a tactical afterthought into a standalone growth engine ?
The logic behind the split is straightforward. By untangling the complex web of Aetna, Caremark, and Oak Street Health from the roughly 9,000 retail pharmacies, CVS Pharmacy will be forced to stand on its own two feet financially. According to retail strategists, that independence means the new entity can no longer rely on the health care side to mask lackluster retail performance. Wendy Liebmann, CEO of WSL Strategic Retail, noted that the separation allows the retail team to “finally focus on retail,” pointing out that health and beauty are the “core category pillars” of that business .
This is a seismic shift for a company that spent two decades building an integrated health-care juggernaut. Under the proposed structure, Prem Shah will take the helm of the standalone CVS Pharmacy, tasked with proving that a drugstore can thrive without the safety net of an insurance giant . For beauty brands and shoppers alike, the implications are significant. A standalone retail business is far more reliant on the high margins and impulse purchases that the front-of-store provides. As industry expert Jeffrey Ten observed, the key question is whether beauty will be treated as a “growth engine that earns capital” rather than merely a “margin backstop for a pharmacy business under pressure” .
The tea leaves suggest CVS is already laying the groundwork for a more premium beauty experience. Recent moves—such as clustering men’s grooming brands together (which reportedly yielded triple-digit growth) and expanding the presence of trained beauty advisers to roughly 700 locations—indicate a desire to compete on discovery and expertise rather than just convenience. Furthermore, the rise of GLP-1 medications presents a unique cross-merchandising opportunity; CVS has noted that users of these drugs over-index in health and beauty products, opening the door for curated skin care and hydration solutions tailored to that specific patient journey.
Of course, the road to 2028 is paved with operational hurdles. Splitting a massive conglomerate is never clean, and the retail landscape remains brutal. But for the first time in years, the beauty aisle at CVS might not just be a pit stop on the way to the pharmacy counter. It might just become the main event.
